scholarly article | Q13442814 |
P356 | DOI | 10.1007/S00381-002-0680-2 |
P698 | PubMed publication ID | 12541081 |
P2093 | author name string | Ihsan Solaroglu | |
Kamer Kilinc | |||
Erkan Kaptanoglu | |||
Etem Beskonakli | |||
Suat Dede | |||
Ali Haberal | |||
Ayse Solaroglu | |||
P433 | issue | 1 | |
P921 | main subject | erythropoietin | Q218706 |
P304 | page(s) | 19-22 | |
P577 | publication date | 2002-12-14 | |
P1433 | published in | Child's Nervous System | Q15762919 |
P1476 | title | Erythropoietin prevents ischemia-reperfusion from inducing oxidative damage in fetal rat brain | |
P478 | volume | 19 |
Q42713131 | Cerebroprotective potential of resveratrol through anti-oxidant and anti-inflammatory mechanisms in rats |
Q35897862 | Discovery and Characterization of Nonpeptidyl Agonists of the Tissue-Protective Erythropoietin Receptor |
Q36059793 | Epo and other hematopoietic factors |
Q35801886 | Erythropoietin (epoetin) as a protective factor for the brain |
Q33443963 | Erythropoietin augments the efficacy of therapeutic angiogenesis induced by allogenic bone marrow stromal cells in a rat model of limb ischemia |
Q44550966 | Erythropoietin exerts neuroprotection after acute spinal cord injury in rats: effect on lipid peroxidation and early ultrastructural findings. |
Q36392457 | Erythropoietin improves skeletal muscle microcirculation and tissue bioenergetics in a mouse sepsis model |
Q42226775 | Erythropoietin neuroprotection with traumatic brain injury |
Q33492716 | Erythropoietin sustains cognitive function and brain volume after neonatal stroke |
Q42922791 | Erythropoietin: a multimodal neuroprotective agent |
Q90957320 | Free radicals and neonatal encephalopathy: mechanisms of injury, biomarkers, and antioxidant treatment perspectives |
Q36225357 | Hypoxia-inducible factor 1-α-AA-modified bone marrow stem cells protect PC12 cells from hypoxia-induced apoptosis, partially through VEGF/PI3K/Akt/FoxO1 pathway |
Q36045209 | Hypoxic preconditioning protects against ischemic brain injury |
Q45976217 | Long-term moderate dose exogenous erythropoietin treatment protects from intermittent hypoxia-induced spatial learning deficits and hippocampal oxidative stress in young rats. |
Q40295428 | Neuroprotection by resveratrol against traumatic brain injury in rats |
Q47802723 | Neuroprotective effects of propofol, thiopental, etomidate, and midazolam in fetal rat brain in ischemia-reperfusion model. |
Q35037632 | New antioxidant drugs for neonatal brain injury. |
Q34569855 | Postnatal erythropoietin treatment mitigates neural cell loss after systemic prenatal hypoxic-ischemic injury |
Q57492270 | Potential application value of xenon in stroke treatment |
Q33879330 | Reperfusion and neurovascular dysfunction in stroke: from basic mechanisms to potential strategies for neuroprotection |
Q37690680 | Role of Antioxidants in Neonatal Hypoxic-Ischemic Brain Injury: New Therapeutic Approaches. |
Q37190629 | Role of signal transducer and activator of transcription 3 in neuronal survival and regeneration |
Q36943612 | Role of signal transducer and activator of transcription-3 in estradiol-mediated neuroprotection |
Q42932529 | The role of erythropoietin in the protection of gastric mucosa from indometacin-induced gastric injury and its relationship with oxidant and antioxidant parameters in rats |
Q34570042 | XENON in medical area: emphasis on neuroprotection in hypoxia and anesthesia |
Q63614928 | Érythropoïétine et neuroprotection |
Search more.